Articles & Resources

Jul 8, 2024

Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy

Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy

Read article

Latest posts

No items found.
Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy
Jul 8, 2024

Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy

FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery
Jun 11, 2024

FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery

ENMEDIA Talks With FluoSphera
May 26, 2024

ENMEDIA Talks With FluoSphera

FluoSphera S.A. is Grant Award Recipient of CHF 1.1 million from Innosuisse
Jan 1, 2024

FluoSphera S.A. is Grant Award Recipient of CHF 1.1 million from Innosuisse

FluoSphera secures $1 million pre-seed investment
Mar 1, 2023

FluoSphera secures $1 million pre-seed investment

LSCV Interview
Jul 26, 2022

LSCV Interview

Things move fast in drug discovery,
so don't get left behind.

‍Subscribe to our Investor Newsletter to keep up with‍ FluoSphera’s milestones ahead of the next fundraising round

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.